SCHEMBL5809221

SCHEMBL5809221

C/C(=N\NC(=O)c1ccncc1)c1c(O)cccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.62
CYP3A4 P08684 2/20 0.59
MTOR P42345 1/20 0.58
MAPT P10636 5/20 0.57
KDM4E B2RXH2 5/20 0.57
ALDH1A1 P00352 4/20 0.57
GFER P55789 3/20 0.57
TDP1 Q9NUW8 2/20 0.56
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
BRCA1 P38398 1/20 0.56
HBB P68871 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HIF1A Q16665 1/20 0.56
POLB P06746 3/20 0.56
KMT2A Q03164 3/20 0.53
NPC1 O15118 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809227 1.00 GAA (0.62) GAACYP3A4MTORMAPTKDM4E
SCHEMBL15772499 0.86 NPC1 (0.60) GAACYP3A4MAPTKDM4EALDH1A1
SCHEMBL14712687 0.86 NPC1 (0.60) GAACYP3A4MAPTKDM4EALDH1A1
SCHEMBL19283299 0.85 KDM1A (0.71) GAACYP3A4MTORMAPTKDM4E
SCHEMBL19283301 0.85 KDM1A (0.71) GAACYP3A4MTORMAPTKDM4E
SCHEMBL5809768 0.84 KDM1A (0.74) GAACYP3A4MAPTKDM4EALDH1A1
SCHEMBL5809772 0.84 KDM1A (0.74) GAACYP3A4MAPTKDM4EALDH1A1
Isonicotinoylhydrazone Of Acetophenone SCHEMBL6637694 0.80 GAA (0.76) GAACYP3A4MTORMAPTKDM4E
Isonicotinoylhydrazone Of Acetophenone SCHEMBL6637701 0.80 GAA (0.76) GAACYP3A4MTORMAPTKDM4E
SCHEMBL23719206 0.78 NPC1 (0.64) GAACYP3A4MTORMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed